SPONSOR
Jonsson Comprehensive Cancer Center
Total Trials
8
Recruiting
8
Phases
Phase 2, Phase 1, Phase 1, Phase 2
Conditions studied: Recurrent Endometrial CarcinomaRecurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal CarcinomaLocally Advanced Rectal CarcinomaRectal AdenocarcinomaStage II Rectal Cancer AJCC v8Stage IIA Rectal Cancer AJCC v8Stage IIB Rectal Cancer AJCC v8Stage IIC Rectal Cancer AJCC v8
Jonsson Comprehensive Cancer Center is a clinical research sponsor with 8 registered studies on ClinicalTrials.gov, of which 8 are actively recruiting participants. Research covers conditions including Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma.
The trial portfolio spans Phase 2, Phase 1, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Jonsson Comprehensive Cancer Center
How many clinical trials has Jonsson Comprehensive Cancer Center sponsored?
ClinicalMetric currently tracks 8 clinical trials sponsored by Jonsson Comprehensive Cancer Center, of which 8 are actively recruiting participants. These trials cover conditions including Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Jonsson Comprehensive Cancer Center research focus on?
Jonsson Comprehensive Cancer Center clinical trials span Recurrent Endometrial Carcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma, Locally Advanced Rectal Carcinoma, and additional conditions. The research pipeline includes Phase 2, Phase 1, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Jonsson Comprehensive Cancer Center clinical trial?
To participate in a Jonsson Comprehensive Cancer Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Jonsson Comprehensive Cancer Center trials with current recruitment status updated daily.
Clinical Trials by Jonsson Comprehensive Cancer Center
NCT04469764 Phase 2
Recruiting
Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer
Recurrent Endometrial Carcinoma
NCT04703101 Phase 1
Recruiting
Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer
Locally Advanced Rectal Carcinoma
NCT06059690 Phase 1, Phase 2
Recruiting
Biologic Association Between Metabolic Magnetic Resonance-positron Emission Tomograph (MR-PET) and Tissue Measures of Glycolysis in Brain Tumors of Infiltrating Glioblastoma Cells
Glioblastoma Multiforme
NCT07310004
Recruiting
Virtual Reality vs. Music Relaxation for Reducing Anxiety and Pain During Breast Biopsies
Breast Biopsy
NCT05688215 Phase 1, Phase 2
Recruiting
Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
Borderline Resectable Pancreatic Adenocarcinoma
NCT04553770 Phase 2
Recruiting
Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
Early-stage Breast Cancer
NCT06980077 Phase 2
Recruiting
Ivonescimab for the Treatment of Thymic Cancer
Thymus Carcinoma
NCT06090903
Recruiting
Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma
Glioblastoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology